Merus Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Merus B.V. (MRUS) IPO Opens Modestly Lower
May 19, 2016 10:28 AM EDTToday's IPO for Merus B.V. (Nasdaq: MRUS) opened for trading at $9.75 after pricing 5,500,000 common shares at an initial public offering price of $10.00 per share, below the expected $14-$16 range. The size of the offering was increased from 4,333,333.
Citigroup Global Markets Inc. and Jefferies LLC are acting as joint book-running managers for the offering, Guggenheim Securities, LLC is acting as lead manager for the offering and Wedbush PacGrow is acting as co-manager for the offering.
Merus B.V. is a clinical-stage immuno-oncology company... More
